Mobile fetal monitoring platform from Cerner wins FDA nod

11/14/2012 | Kansas City Star (Mo.), The

The FDA has cleared Cerner to market its FetaLink+ fetal monitoring system. The technology is designed to allow clinicians to use their iPads or iPhones to access fetal and maternal data in near-real time and make informed medical decisions.

View Full Article in:

Kansas City Star (Mo.), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL